{
  "schema_version": "pdp_json_v1",
  "peptide": {
    "canonical_name": "SS-31 (Elamipretide)",
    "classification": {
      "category": "approved_human",
      "needs_prescription": true,
      "notes": "SS-31 (elamipretide) is a mitochondria-targeting peptide studied clinically for mitochondrial dysfunction-related conditions."
    },
    "status": {
      "category": "approved_human",
      "human_use_note": "Prescription drug in certain jurisdictions; this app provides educational information only."
    },
    "risk": {
      "current_score": 6,
      "severity": "moderate",
      "likelihood": "possible",
      "evidence_grade": "regulatory_label",
      "rationale": "Human clinical exposure exists; risks depend on indication, dosing, and patient factors.",
      "unknowns_penalty": true,
      "developmental_risk": true
    },
    "sections": {
      "overview": [
        {
          "text": "SS-31 (elamipretide) is a mitochondria-targeting peptide that binds cardiolipin and is studied for improving mitochondrial function. This is an educational summary; see evidence links.",
          "evidence_refs": [
            "E1"
          ]
        }
      ]
    },
    "evidence": [
      {
        "id": "E1",
        "title": "SS-31 (Elamipretide) â€” PubMed search (reference index)",
        "source_type": "website",
        "source_id": "https://pubmed.ncbi.nlm.nih.gov/?term=elamipretide%20SS-31",
        "evidence_grade": "human_interventional"
      }
    ]
  }
}
